Table 5C.
Recruiting Clinical Trial.
| Therapy | Ab clone | ID | Cancer type | Description | Study start date |
|---|---|---|---|---|---|
| CAR-T | N/A | NCT04404595 | Gastric, pancreatic or other digestive cancers | Phase Ib/II | 2020 |
| CAR-T CT041 | N/A | NCT04581473 | GC/GEJ and pancreatic cancer | Phase I/II | 2020 |
| CAR-TILs | N/A | NCT04842812 | Advanced solid tumors | Phase I | 2021 |
| CAR-T | N/A | NCT05620732 | Advanced solid tumors | Phase I | 2022 |
| CAR-T | N/A | NCT05583201 | Solid tumors | Phase I | 2022 |
| CAR-T | N/A | NCT05472857 | Advanced solid tumors | Phase I | 2022 |
| CAR-T | N/A | NCT05277987 | GC/GEJ and pancreatic cancer | Phase I | 2022 |
| CAR-T | N/A | NCT05393986 | Solid tumors | Phase I | 2022 |
| CAR-T | AZD6422 | NCT05981235 | Gastrointestinal tumors | Phase I | 2023 |
| CAR-T | N/A | NCT05952375 | Advanced solid tumors | Phase I | 2023 |
| CAR-T | N/A | NCT05539430 | Advanced GC/GEJ or pancreatic adenocarcinoma | Phase I | 2023 |
| CAR-T CT041 | N/A | NCT05911217 | Pancreatic cancer | Phase Ib | 2023 |
| TAC T-cells TACTIC-3 | N/A | NCT05862324 | Metastatic solid tumors | Phase I, II | 2023 |
N/A, Not applicable.